Europe — EMA
Fibclot (Human Fibrinogen)
Human Fibrinogen (Fibclot) is a clotting factor used to manage bleeding disorders. This intravenous medication supports blood coagulation, crucial for surgical
Request sourcing
What is Human Fibrinogen?
Human Fibrinogen (Fibclot) is a clotting factor used to manage bleeding disorders. This intravenous medication supports blood coagulation, crucial for surgical or trauma-related bleeding. Learn more about its uses and effects.
What is Human Fibrinogen used for?
Human Fibrinogen, marketed as Fibclot, is primarily used to control bleeding in individuals with congenital fibrinogen deficiency. It is often administered intravenously to support blood clotting during surgical procedures or in cases of trauma. This medication is designed to help manage bleeding episodes by replenishing fibrinogen levels in the bloodstream.
What are the side effects of Human Fibrinogen?
Common effects of Human Fibrinogen may include localized reactions at the injection site, such as redness or swelling. Some individuals might experience mild allergic reactions. It is important to monitor for any adverse reactions and consult a healthcare provider if concerns arise.
What precautions apply to Human Fibrinogen?
Human Fibrinogen should be handled with care, ensuring proper storage and administration protocols are followed. Individuals with known allergies to fibrinogen or its components should avoid its use. Always follow the guidance of a healthcare professional when using this medication.
What does Human Fibrinogen interact with?
Human Fibrinogen may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare provider.



